Cyclophosphamide as second-line therapy in multiple sclerosis: benefits and risks

Title
Cyclophosphamide as second-line therapy in multiple sclerosis: benefits and risks
Authors
Keywords
-
Journal
NEUROLOGICAL SCIENCES
Volume 30, Issue S2, Pages 171-173
Publisher
Springer Nature
Online
2009-10-31
DOI
10.1007/s10072-009-0145-4

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started